You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-PPAR-NXT629
NXT629

Chemical Structure : NXT629

CAS No.: 1454925-59-7

NXT629 (NXT-629)

Catalog No.: PC-72656Not For Human Use, Lab Use Only.

NXT629 (NXT-629) is a potent, selective PPARα antagonist with IC50 of 78 nM, no effect against PPARδ and PPARγ (IC50>30 uM).

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

NXT629 (NXT-629) is a potent, selective PPARα antagonist with IC50 of 77 nM (human PPARα), no effect against PPARδ and PPARγ (IC50>30 uM).
NXT629 inhibited agonist-induced transcription of PPARα-regulated genes, demonstrating target engagement in chronic lymphocytic leukemia (CLL) cells.
NXT629 induced apoptosis of CLL cells even in the presence of a protective microenvironment.
NXT629 reduces the number of chronic leukemia cells undergoing cell division with IC50 of 9.6 uM.
NXT629 reduces CLL tumor burden delays disease progression of CLL in CLL mouse model.

Physicochemical Properties

M.Wt 609.789
Formula C35H39N5O3S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Month
Shipping
Solubility

Chemical Name/SMILES

References

1. Messmer D, et al. Mol Med. 2015 Jun 9;21(1):410-9.

2. Stebbins KJ, et al. Eur J Pharmacol. 2017 Aug 15;809:130-140.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: